| ||||||||||||||
|
|
|||||||||||||



*Professor of Anesthesia, University of California, San Diego, Veterans Administration Hospital, San Diego, Department of Anesthesia, University of California, San Diego
Senior Research Associate, Palo Alto Medical Research Foundation, Palo Alto, Palo Alto Medical Research Foundation, Palo Alto
Research Associate, Palo Alto Medical Research Foundation, Palo Alto, Palo Alto Medical Research Foundation, Palo Alto
Associate Professor of Radiology, Stanford University Medical Center, Stanford. Department of Radiology, Stanford University
Abstract
We investigated the possibility that myocardial asynergy (dyscoordinate contraction) is a contributing mechanism to the impairment of cardiac function produced by halothane. Coronary cineangiograms were performed in seven dogs, awake and at 1, 2, and 3 MAC halothane. The relative motions between four arterial bifurcations (six segments) were plotted as an indication of changing ventricular dimensions. To quantitate ventricular asynergy, we calculated anisotropy (Al) and asynchrony (AS), the coefficient of variation of mean shortening (OV0408) and of mean time to half shortening (OV037450), respectively,_of the six segments. From these a myocardial performance index (MPI) was derived: MPI = OV0408/AI + OV037450 + AS.
In general, OV0408 and MPI decreased with increasing halothane concentration. Anisotropy showed a trend, although usually insignificant, toward increasing, while AS did not change.
These observations have two implications. First, asynergy of contraction contributes little, if anything, to halothane-induced impairment of myocardial performance. Second, changes in measurements of intact cardiac performance, such as dP/dtmax, may be reasonably valid during halothane, provided loading conditions are taken into account.
Key Words: ANESTHETICS, Volatile: halothane; HEART: myocardial function.
|